Ambry Genetics and Invicro Announce Partnership
Menu

Ambry Genetics and Invicro Announce Partnership

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today they will partner with Invicro, a leading provider of imaging services and software for research and drug development, to provide customized genomics and imaging services for the pharmaceutical and biotechnology industry, with a specialized focus on oncology and neurodegenerative diseases.

All products represented on Konica Minolta Healthcare Americas, Inc. website may not have been licensed in accordance with Canadian law.
©2014 Konica Minolta Healthcare Americas, Inc.

AeroDR®, AeroSync®, DRYPRO®, FlexDR®, IMAGEPILOT®, informity®, IQUE®, PrintLink®, REGIUS®, SONIMAGE®, and Xpress CR® are registered marks of Konica Minolta Healthcare Americas, Inc.

AeroRemote™, KDR™, SKR™, SNIBLE™, SNV™, T2HI™, VIRSERBEST™, VIZION™, EXA™ and OPAL-RAD™ are registered trademarks of Konica Minolta Healthcare Americas, Inc.

All products represented on Konica Minolta Healthcare Americas, Inc. website may not have been licensed in accordance with Canadian law.

AeroDR®, AeroRemote®, AeroSync®, DRYPRO®, EXA®, IMAGEPILOT®, KDR®, OPAL-RAD®, REGIUS® SNV®, SONIMAGE®, UGPLearningHub®, UGPro® and Xpress CR® are registered marks of Konica Minolta Healthcare Americas, Inc.

Realism™and Symmetry™ are trademarks of Konica Minolta Healthcare Americas, Inc.